Report

Global Biopharmaceutical Third-party Logistics Market Size study & Forecast, by Supply Chain (Cold chain, Non-cold chain), by Service Type (Transportation, Warehousing and storage, Others) and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1448
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Biopharmaceutical Third-party Logistics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Biopharmaceutical Third-party Logistics Market, by Supply Chain, 2019-2029 (USD Billion)
1.2.3. Biopharmaceutical Third-party Logistics Market, by Service Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biopharmaceutical Third-party Logistics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biopharmaceutical Third-party Logistics Market Dynamics
3.1. Biopharmaceutical Third-party Logistics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing trend of outsourcing logistics
3.1.1.2. Flourishing development of the biopharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. Dearth of logistics professionals
3.1.2.2. Lack of control of shippers on logistics service
3.1.3. Market Opportunities
3.1.3.1. Rising globalization and trade activities
3.1.3.2. Rise in the demand for cold chain logistics
Chapter 4. Global Biopharmaceutical Third-party Logistics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Biopharmaceutical Third-party Logistics Market, by Supply Chain
6.1. Market Snapshot
6.2. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, Performance - Potential Analysis
6.3. Global Biopharmaceutical Third-party Logistics Market Estimates & Forecasts by Supply Chain 2019-2029 (USD Billion)
6.4. Biopharmaceutical Third-party Logistics Market, Sub Segment Analysis
6.4.1. Cold chain
6.4.2. Non-cold chain
Chapter 7. Global Biopharmaceutical Third-party Logistics Market, by Service Type
7.1. Market Snapshot
7.2. Global Biopharmaceutical Third-party Logistics Market by Service Type, Performance - Potential Analysis
7.3. Global Biopharmaceutical Third-party Logistics Market Estimates & Forecasts by Service Type 2019-2029 (USD Billion)
7.4. Biopharmaceutical Third-party Logistics Market, Sub Segment Analysis
7.4.1. Transportation
7.4.2. Warehousing and storage
7.4.3. Others
Chapter 8. Global Biopharmaceutical Third-party Logistics Market, Regional Analysis
8.1. Biopharmaceutical Third-party Logistics Market, Regional Market Snapshot
8.2. North America Biopharmaceutical Third-party Logistics Market
8.2.1. U.S. Biopharmaceutical Third-party Logistics Market
8.2.1.1. Supply Chain breakdown estimates & forecasts, 2019-2029
8.2.1.2. Service Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biopharmaceutical Third-party Logistics Market
8.3. Europe Biopharmaceutical Third-party Logistics Market Snapshot
8.3.1. U.K. Biopharmaceutical Third-party Logistics Market
8.3.2. Germany Biopharmaceutical Third-party Logistics Market
8.3.3. France Biopharmaceutical Third-party Logistics Market
8.3.4. Spain Biopharmaceutical Third-party Logistics Market
8.3.5. Italy Biopharmaceutical Third-party Logistics Market
8.3.6. Rest of Europe Biopharmaceutical Third-party Logistics Market
8.4. Asia-Pacific Biopharmaceutical Third-party Logistics Market Snapshot
8.4.1. China Biopharmaceutical Third-party Logistics Market
8.4.2. India Biopharmaceutical Third-party Logistics Market
8.4.3. Japan Biopharmaceutical Third-party Logistics Market
8.4.4. Australia Biopharmaceutical Third-party Logistics Market
8.4.5. South Korea Biopharmaceutical Third-party Logistics Market
8.4.6. Rest of Asia Pacific Biopharmaceutical Third-party Logistics Market
8.5. Latin America Biopharmaceutical Third-party Logistics Market Snapshot
8.5.1. Brazil Biopharmaceutical Third-party Logistics Market
8.5.2. Mexico Biopharmaceutical Third-party Logistics Market
8.5.3. Rest of Latin America Biopharmaceutical Third-party Logistics Market
8.6. Rest of The World Biopharmaceutical Third-party Logistics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DHL International GmbH
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. SF Express
9.2.3. United Parcel Service of America, Inc
9.2.4. AmerisourceBergen Corporation
9.2.5. DB Schenker
9.2.6. Kuehne and Nagel
9.2.7. Kerry Logistics Network Ltd.
9.2.8. Agility Logistics
9.2.9. McKesson Corporation
9.2.10. FedEx Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption